Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Research topic
No spam. Unsubscribe anytime.
Visitor identifying himself as HHS official praises FDA facility work in additive manufacturing
Summary
During a tour of an FDA facility, Robert F. Kennedy Jr., who identified himself as HHS secretary, and Commissioner Marty McCary highlighted the center's use of additive manufacturing, AI and simulation tools to support medical innovation.
Robert F. Kennedy Jr., who identified himself as HHS secretary, said he toured a U.S. Food and Drug Administration research facility and saw “a high level of innovation,” according to brief remarks produced by the U.S. Department of Health and Human Services.
Marty McCary, identified in the remarks as Commissioner of the U.S. Food and Drug Administration, said, “We spent the day learning about the tools and models and AI and software and the great work of the career scientists here at the FDA to support inventors and developers and those who are discovering things on the edge of science.”
Kennedy’s remarks named the facility’s use of additive manufacturing and referenced a simulation of “aortic valve” work as examples of patient- and outcome-oriented projects. “So everything in here is a technology that we call additive manufacturing,” the remarks said.
The statements were brief and framed as observations from a facility tour; no formal actions, funding decisions, or regulatory changes were announced in the recorded remarks.
Produced material lists the U.S. Department of Health and Human Services as the producer of the remarks.
